Press Releases for the Psychedelics Industry

Psychedelics News

Press Releases

1 Dec 2020

Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial

Centre for Human Drug Research led DMT study to start in 2021 Vancouver, BC – December 1, 2020 – Entheon Biomedical Corp....

By Microdose

Press Releases

25 Nov 2020

MindMed to Launch Albert, A Digital Medicine Division for Psychedelic Medicines

NEW YORKNov....

By Microdose

Press Releases

25 Nov 2020

MindMed Upsizes Previously Announced Bought Deal Public Offering

/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES NEW YORKNov....

By Microdose

Press Releases

25 Nov 2020

MindMed Announces $25 Million Bought Deal Public Offering

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

16 Nov 2020

MindMed Receives Approval of Protocol Design to Evaluate Microdoses of LSD For Adult ADHD In Phase 2a Clinical Trial from Swiss and Dutch Health Authorities

Project Lucy Submits Pre-IND Briefing Package to the FDA; Agrees Q1 Interim Analysis of Swiss Phase 2a Trial of LSD Assisted Therapy for Anxiety Disorders NEW YORKBASEL, SwitzerlandNov....

By Microdose

Press Releases

12 Nov 2020

COMPASS Pathways plc announces financial results for third quarter 2020

Highlights include $146....

By Microdose

Press Releases

11 Nov 2020

Revive Therapeutics Provides Update on Oral Thin Film Product with Psilocybin

TORONTO, Nov....

By Microdose

Press Releases

9 Nov 2020

COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care

London, UK – 9 November 2020 Read more on Microdose...

By Microdose

Press Releases

6 Nov 2020

Entheon Announces Completion of Amalgamation and Final Approval from the Canadian Securities Exchange

Original Source – Newsfile Corp....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result